Efficacy of single versus three sessions of high rate repetitive transcranial magnetic stimulation in chronic migraine and tension-type headache

Abstract

We report the efficacy of three versus single session of 10 Hz repetitive transcranial magnetic stimulation (rTMS) in chronic migraine (CM) and chronic tension-type headache (CTTH). Ninety-eight patients with CM or CTTH were included and their headache frequency, severity, functional disability and number of abortive medications were noted. Fifty-two patients were randomly assigned to group I (three true sessions) and 46 to group II (one true and two sham rTMS sessions) treatment. 10 Hz rTMS comprising 600 pulses was delivered in 412.4 s on the left frontal cortex. Outcomes were noted at 1, 2 and 3 months. The primary outcome was 50 % reduction in headache frequency, and secondary outcomes were improvement in severity, functional disability, abortive drugs and side effects. The baseline headache characteristics were similar between the two groups. Follow up at different time points revealed significant improvement in headache frequency, severity, functional disability and number of abortive drugs compared to baseline in both group I and group II patients, although these parameters were not different between the two groups. In group I, 31 (79.4 %) had reduction of headache frequency and 29 (74.4 %) converted to episodic headache. In group II, these were 24 (64.8 %) and 22 (59.2 %), respectively. In chronic migraine, the severity of headache at 2 months reduced in group I compared to group II (62.5 vs 35.3 %; P = 0.01). Both single and three sessions of 10 Hz rTMS were found to be equally effective in CM and CTTH, and resulted in conversion of chronic to episodic headache in 67.1 % patients.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Silberstein SD (1993) Tension-type and chronic daily headache. Neurology 43(9):1644–1649

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Bigal ME, Sheftell FD (2006) Chronic daily headache and its subtypes. Continuum-Lifelong Learn Neurol 12(6):133–152

    Article  Google Scholar 

  3. 3.

    Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, AMPP Advisory Group (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68(5):343–349

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L, Lipton RB (2010) Global prevalence of chronic migraine: a systematic review. Cephalalgia 30(5):599–609

    CAS  PubMed  Google Scholar 

  5. 5.

    Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MF, Tierce J, Reed M, Lipton RB (2009) Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache 49(4):498–508

    Article  PubMed  Google Scholar 

  6. 6.

    Kalita J, Bhoi SK, Misra UK (2013) Amitriptyline vs divalproate in migraine prophylaxis: a randomized controlled trial. Acta Neurol Scand 128(1):65–72

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Jackson JL, Cogbill E, Santana-Davila R, Eldredge C, Collier W, Gradall A, Sehgal N, Kuester J (2015) A comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache. PLoS One 10(7):e0130733

    Article  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Mathew NT, Jaffri SF (2009) A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study. Headache 49(10):1466–1478

    Article  PubMed  Google Scholar 

  9. 9.

    Bhola R, Kinsella E, Giffin N, Lipscombe S, Ahmed F, Weatherall M, Goadsby PJ (2015) Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program. J Headache Pain 16:535

    Article  PubMed  Google Scholar 

  10. 10.

    Misra UK, Kalita J, Bhoi SK (2013) High-rate repetitive transcranial magnetic stimulation in migraine prophylaxis: a randomized, placebo-controlled study. J Neurol 260(11):2793–2801

    Article  PubMed  Google Scholar 

  11. 11.

    Headache Classification Subcommittee of the International Headache Society (IHS) (2005) The International Classification of Headache Disorders. 2nd edition. 1st revision. Cephalalgia 25:460–465

    Article  Google Scholar 

  12. 12.

    Headache Classification Committee of the International Headache Society (IHS) (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33(9):629–808

    Article  Google Scholar 

  13. 13.

    Kalita J, Yadav RK, Misra UK (2009) A comparison of migraine patients with and without allodynic symptoms. Clin J Pain 25(8):696–708

    Article  PubMed  Google Scholar 

  14. 14.

    Yadav RK, Kalita J, Misra UK (2010) A study of triggers of migraine in India. Pain Med 11(1):44–47

    Article  PubMed  Google Scholar 

  15. 15.

    Conforto AB, Amaro E Jr, Gonçalves AL, Mercante JP, Guendler VZ, Ferreira JR, Kirschner CC, Peres MF (2014) Randomized, proof-of-principle clinical trial of active transcranial magnetic stimulation in chronic migraine. Cephalalgia 34(6):464–472

    Article  PubMed  Google Scholar 

  16. 16.

    Misra UK, Kalita J, Bhoi SK (2012) High frequency repetitive transcranial magnetic stimulation (rTMS) is effective in migraine prophylaxis: an open labeled study. Neurol Res 34(6):547–551

    Article  PubMed  Google Scholar 

  17. 17.

    Brighina F, Piazza A, Vitello G, Aloisio A, Palermo A, Daniele O, Fierro B (2004) rTMS of the prefrontal cortex in the treatment of chronic migraine: a pilot study. J Neurol Sci 227(1):67–71

    Article  PubMed  Google Scholar 

  18. 18.

    Teepker M, Hotzel J, Timmesfeld N, Reis J, Mylius V, Haag A, Oertel WH, Rosenow F, Schepelmann K (2010) Low-frequency rTMS of the vertex in the prophylactic treatment of migraine. Cephalalgia 30(2):137–144

    CAS  PubMed  Google Scholar 

  19. 19.

    Brighina F, de Tommaso M, Giglia F, Scalia S, Cosentino G, Puma A, Panetta M, Giglia G, Fierro B (2011) Modulation of pain perception by transcranial magnetic stimulation of left prefrontal cortex. J Headache Pain 12(2):185–191

    Article  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Meng FG, Zhang JG, Schoenen J, Vandersmissen B, Herroelen L, Vandenheede M, Gerard P, Magis D (2013) Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology 81(12):1102

    Article  PubMed  Google Scholar 

  21. 21.

    Brighina F, Palermo A, Panetta ML, Daniele O, Aloisio A, Cosentino G, Fierro B (2009) Reduced cerebellar inhibition in migraine with aura: a TMS study. Cerebellum 8(3):260–266

    Article  PubMed  Google Scholar 

  22. 22.

    Fumal A, Bohotin V, Vandenheede M, Schoenen J (2003) Transcranial magnetic stimulation in migraine: a review of facts and controversies. Acta Neurol Belg 103(3):144–154

    PubMed  Google Scholar 

  23. 23.

    Klein MM, Treister R, Raij T, Pascual-Leone A, Park L, Nurmikko T et al (2015) Transcranial magnetic stimulation of the brain: guidelines for pain treatment research. Pain 156(9):1601–1614

    Article  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Coppola G, Currà A, Di Lorenzo C, Parisi V, Gorini M, Sava SL, Schoenen J, Pierelli F (2010) Abnormal cortical responses to somatosensory stimulation in medication-overuse headache. BMC Neurol 10:126

    Article  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Kropp P, Gerber WD (1993) Is increased amplitude of contingent negative variation in migraine due to cortical hyperactivity or to reduced habituation? Cephalalgia 13(1):37–41

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    Kalita J, Bhoi SK, Misra UK (2014) Is lack of habituation of evoked potential a biological marker of migraine? Clin J Pain 30(8):724–729

    Article  PubMed  Google Scholar 

  27. 27.

    Fumal A, Coppola G, Bohotin V, Gérardy PY, Seidel L, Donneau AF et al (2006) Induction of long-lasting changes of visual cortex excitability by five daily sessions of repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers and migraine patients. Cephalalgia 26(2):143–149

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Misra UK, Kalita J, Tripathi GM, Bhoi SK (2013) Is β endorphin related to migraine headache and its relief? Cephalalgia 33(5):316–322

    Article  PubMed  Google Scholar 

  29. 29.

    Maniyar FH, Sprenger T, Monteith T, Schankin C, Goadsby PJ (2014) Brain activation in the premonitory phase of nitroglycerin—triggered migraine attacks. Brain 137(1):232–241

    Article  PubMed  Google Scholar 

  30. 30.

    Czéh B, Welt T, Fischer AK, Erhardt A, Schmitt W, Müller MB, Toschi N, Fuchs E, Keck ME (2002) Chronic psychosocial stress and concomitant repetitive transcranial magnetic stimulation: effects on stress hormone levels and adult hippocampal neurogenesis. Biol Psychiatry 52(11):1057–1065

    Article  PubMed  Google Scholar 

  31. 31.

    Cho SS, Strafella AP (2009) rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex. PLoS One 4(8):e6725

    Article  PubMed  PubMed Central  Google Scholar 

  32. 32.

    Michael N, Gösling M, Reutemann M, Kersting A, Heindel W, Arolt V, Pfleiderer B (2003) Metabolic changes after repetitive transcranial magnetic stimulation (rTMS) of the left prefrontal cortex: a sham-controlled proton magnetic resonance spectroscopy (1H MRS) study of healthy brain. Eur J Neurosci 17(11):2462–2468

    Article  PubMed  Google Scholar 

  33. 33.

    Manack A, Buse DC, Serrano D, Turkel CC, Lipton RB (2011) Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology 76(8):711–718

    CAS  Article  PubMed  Google Scholar 

  34. 34.

    Silberstein SD, Dodick DW, Lindblad AS, Holroyd K, Harrington M, Mathew NT et al (2012) Randomized, placebo controlled trial of propranolol added to topiramate in chronic migraine. Neurology 78(27):976–984

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Bussone G, Diener HC, Pfeil J, Schwalen S (2005) Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Int J Clin Pract 59(8):961–968

    CAS  Article  PubMed  Google Scholar 

  36. 36.

    Yang CP, Chang MH, Li TC, Hsieh CL, Hwang KL, Chang HH (2013) Predicting prognostic factors in a randomized controlled trial of acupuncture versus topiramate treatment in patients with chronic migraine. Clin J Pain 29(11):982–987

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Mr. Rakesh Kumar Nigam and Mr. Shakti Kumar for secretarial help.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Usha Kant Misra.

Ethics declarations

Conflicts of interest

There is no conflict of interest to declare.

Ethical approval

This study was approved by Institutional Ethics Committee, SGPGIMS, Lucknow, India.

Electronic supplementary material

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kalita, J., Laskar, S., Bhoi, S.K. et al. Efficacy of single versus three sessions of high rate repetitive transcranial magnetic stimulation in chronic migraine and tension-type headache. J Neurol 263, 2238–2246 (2016). https://doi.org/10.1007/s00415-016-8257-2

Download citation

Keywords

  • Chronic daily headache
  • Chronic tension-type headache
  • Chronic migraine
  • Magnetic stimulation
  • Migraine prophylaxis